Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 Chronic Kidney Disease.

Ravani P, Fiocco M, Liu P, Quinn RR, Hemmelgarn B, James M, Lam N, Manns B, Oliver MJ, Strippoli GFM, Tonelli M.

J Am Soc Nephrol. 2019 Sep 20. pii: ASN.2019060640. doi: 10.1681/ASN.2019060640. [Epub ahead of print]

PMID:
31540963
2.

Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.

Viecelli AK, Howell M, Tong A, Teixeira-Pinto A, O'Lone E, Ju A, Craig JC, Hooi LS, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani TJ, Vanholder R, Zuo L, Tordoir J, Pecoits-Filho R, Yuo T, Kopperschmidt P, Smith R, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Nephrol Dial Transplant. 2019 Aug 1. pii: gfz148. doi: 10.1093/ndt/gfz148. [Epub ahead of print]

PMID:
31369099
3.

Timing of Fistula Creation and the Probability of Catheter-Free Use: A Cohort Study.

Clarke A, Ravani P, Oliver MJ, Hiremath S, Blake PG, Moist LM, Garg AX, Lam NN, Quinn RR.

Can J Kidney Health Dis. 2019 May 7;6:2054358119843139. doi: 10.1177/2054358119843139. eCollection 2019.

4.

Patient and provider experience and perspectives of a risk-based approach to multidisciplinary chronic kidney disease care: a mixed methods study.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Thomas C, Weaver RG, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR.

BMC Nephrol. 2019 Mar 29;20(1):110. doi: 10.1186/s12882-019-1269-2.

5.

Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study.

Liu P, Quinn RR, Karim ME, Bello A, Tam-Tham H, Weaver R, Ronksley PE, Quan H, Strippoli GFM, Manns B, Hemmelgarn BR, Tonelli M, Ravani P.

CMAJ. 2019 Mar 11;191(10):E274-E282. doi: 10.1503/cmaj.181372.

6.

Outcomes Following Macrolide Use in Kidney Transplant Recipients.

Jeong R, Quinn RR, Lentine KL, Lloyd A, Ravani P, Hemmelgarn B, Braam B, Garg AX, Wen K, Wong-Chan A, Gourishankar S, Lam NN.

Can J Kidney Health Dis. 2019 Feb 21;6:2054358119830706. doi: 10.1177/2054358119830706. eCollection 2019.

7.

Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.

Poinen K, Quinn RR, Clarke A, Ravani P, Hiremath S, Miller LM, Blake PG, Oliver MJ.

Am J Kidney Dis. 2019 Apr;73(4):467-475. doi: 10.1053/j.ajkd.2018.10.014. Epub 2019 Jan 12.

PMID:
30642607
8.

Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

Lam NN, Klarenbach S, Quinn RR, Hemmelgarn B, Tonelli M, Ye F, Ravani P, Bello AK, Brennan DC, Lentine KL.

Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.

9.

Socioeconomic Status and Kidney Transplant Outcomes in a Universal Healthcare System: A Population-based Cohort Study.

Naylor KL, Knoll GA, Shariff SZ, McArthur E, Garg AX, Van Walraven C, Austin PC, McCallum MK, Quinn RR, Tan VS, Kim SJ.

Transplantation. 2019 May;103(5):1024-1035. doi: 10.1097/TP.0000000000002383.

PMID:
30247444
10.

Outcomes of the First and Second Hemodialysis Fistula: A Cohort Study.

Kamar F, Quinn RR, Oliver MJ, Viecelli AK, Hiremath S, MacRae J, Miller L, Blake P, Moist L, Garg AX, Lam NN, Kabani R, Clarke A, Liu P, Gillespie B, Ravani P.

Am J Kidney Dis. 2019 Jan;73(1):62-71. doi: 10.1053/j.ajkd.2018.06.007. Epub 2018 Aug 16.

PMID:
30122545
11.

Follow-up Care of Living Kidney Donors in Alberta, Canada.

Lam NN, Lentine KL, Hemmelgarn B, Klarenbach S, Quinn RR, Lloyd A, Gourishankar S, Garg AX.

Can J Kidney Health Dis. 2018 Jul 26;5:2054358118789366. doi: 10.1177/2054358118789366. eCollection 2018.

12.

Thiazide Diuretic Dose and Risk of Kidney Stones in Older Adults: A Retrospective Cohort Study.

Alexander RT, McArthur E, Jandoc R, Welk B, Fuster DG, Garg AX, Quinn RR.

Can J Kidney Health Dis. 2018 Jul 15;5:2054358118787480. doi: 10.1177/2054358118787480. eCollection 2018.

13.

Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.

Tam-Tham H, Quinn RR, Weaver RG, Zhang J, Ravani P, Liu P, Thomas C, King-Shier K, Fruetel K, James MT, Manns BJ, Tonelli M, Murtagh FEM, Hemmelgarn BR.

Kidney Int. 2018 Sep;94(3):582-588. doi: 10.1016/j.kint.2018.03.007. Epub 2018 May 24.

PMID:
29803405
14.

Perceived Benefits and Challenges of a Risk-Based Approach to Multidisciplinary Chronic Kidney Disease Care: A Qualitative Descriptive Study.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR.

Can J Kidney Health Dis. 2018 Mar 23;5:2054358118763809. doi: 10.1177/2054358118763809. eCollection 2018.

15.

Association between Duration of Predialysis Care and Mortality after Dialysis Start.

Liu P, Quinn RR, Oliver MJ, Ronksley PE, Hemmelgarn BR, Quan H, Hiremath S, Bello AK, Blake PG, Garg AX, Johnson J, Verrelli M, Zacharias JM, Abd ElHafeez S, Tonelli M, Ravani P.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):893-899. doi: 10.2215/CJN.11951017. Epub 2018 Mar 5.

16.

Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.

Viecelli AK, Tong A, O'Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E, Hooi LS, Johnson DW, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Hawley CM; SONG-HD Vascular Access Workshop Investigators.

Am J Kidney Dis. 2018 May;71(5):690-700. doi: 10.1053/j.ajkd.2017.12.003. Epub 2018 Feb 23. Review.

PMID:
29478866
17.

Controversies in vascular access.

Papini A, Ravani P, Quinn RR.

Curr Opin Nephrol Hypertens. 2018 May;27(3):209-213. doi: 10.1097/MNH.0000000000000403. Review.

PMID:
29406363
18.

Implementation and Evaluation of a Risk-Based Approach to Guide Chronic Kidney Disease Care: Protocol for a Multiphase Mixed-Methods Study.

Hemmelgarn BR, Smekal MD, Weaver RG, Thomas C, Benterud E, Tam K, Manns BJ, Tonelli M, Finlay J, Donald M, Tam-Tham H, Bello A, Tangri N, Quinn RR.

Can J Kidney Health Dis. 2018 Jan 17;5:2054358117753618. doi: 10.1177/2054358117753618. eCollection 2018.

19.

Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR, Tonelli M, Kiaii M, Mossop P, Scott-Douglas N.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):429-435. doi: 10.2215/CJN.08510817. Epub 2018 Jan 15.

20.

Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.

Viecelli AK, O'Lone E, Sautenet B, Craig JC, Tong A, Chemla E, Hooi LS, Lee T, Lok C, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Am J Kidney Dis. 2018 Mar;71(3):382-391. doi: 10.1053/j.ajkd.2017.09.018. Epub 2017 Dec 6.

PMID:
29203125
21.

Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.

Wong B, Ravani P, Oliver MJ, Holroyd-Leduc J, Venturato L, Garg AX, Quinn RR.

Am J Kidney Dis. 2018 Mar;71(3):344-351. doi: 10.1053/j.ajkd.2017.08.028. Epub 2017 Nov 22.

PMID:
29174322
22.

Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.

James MT, Pannu N, Hemmelgarn BR, Austin PC, Tan Z, McArthur E, Manns BJ, Tonelli M, Wald R, Quinn RR, Ravani P, Garg AX.

JAMA. 2017 Nov 14;318(18):1787-1797. doi: 10.1001/jama.2017.16326.

23.

Can Home Hemodialysis and Peritoneal Dialysis Programs Coexist and Grow Together?

Shah N, Quinn RR, Thompson S, Pauly RP.

Perit Dial Int. 2017 Nov-Dec;37(6):591-594. doi: 10.3747/pdi.2017.00101. No abstract available.

PMID:
29122999
24.

Central venous catheters for chronic hemodialysis: Is "last choice" never the "right choice"?

Dumaine CS, Brown RS, MacRae JM, Oliver MJ, Ravani P, Quinn RR.

Semin Dial. 2018 Jan;31(1):3-10. doi: 10.1111/sdi.12655. Epub 2017 Nov 2. Review.

PMID:
29098715
25.

Randomized Crossover Trial of Blood Volume Monitoring-Guided Ultrafiltration Biofeedback to Reduce Intradialytic Hypotensive Episodes with Hemodialysis.

Leung KCW, Quinn RR, Ravani P, Duff H, MacRae JM.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1831-1840. doi: 10.2215/CJN.01030117. Epub 2017 Oct 10.

26.

Trends in the Management of Patients With Kidney Failure in Alberta, Canada (2004-2013).

Chong CC, Tam-Tham H, Hemmelgarn BR, Weaver RG, Scott-Douglas N, Tonelli M, Quinn RR, Manns L, Manns BJ.

Can J Kidney Health Dis. 2017 Mar 22;4:2054358117698668. doi: 10.1177/2054358117698668. eCollection 2017.

27.

Peritoneal Dialysis: A Scoping Review of Strategies to Maximize PD Utilization.

Mann BS, Manns BJ, Barnieh L, Oliver MJ, Devoe D, Lorenzetti D, Pauly R, Quinn RR.

Perit Dial Int. 2017 Mar-Apr;37(2):159-164. doi: 10.3747/pdi.2016.00057. Review.

PMID:
28360367
28.

Antihypertensive medications and the risk of kidney stones in older adults: a retrospective cohort study.

Alexander RT, McArthur E, Jandoc R, Welk B, Hayward JS, Jain AK, Braam B, Flockerzi V, Garg AX, Quinn RR.

Hypertens Res. 2017 Sep;40(9):837-842. doi: 10.1038/hr.2017.42. Epub 2017 Mar 23.

PMID:
28331214
29.

Selection of peritoneal dialysis among older eligible patients with end-stage renal disease.

Wong B, Venturato L, Oliver MJ, Quinn RR, Ravani P, Holroyd-Leduc J.

Nephrol Dial Transplant. 2017 Feb 1;32(2):384-392. doi: 10.1093/ndt/gfw367.

PMID:
28186576
30.

The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death.

Quinn RR, Oliver MJ, Devoe D, Poinen K, Kabani R, Kamar F, Mysore P, Lewin AM, Hiremath S, MacRae J, James MT, Miller L, Hemmelgarn BR, Moist LM, Garg AX, Chowdhury TT, Ravani P.

J Am Soc Nephrol. 2017 Feb;28(2):613-620. doi: 10.1681/ASN.2016020151. Epub 2016 Oct 6.

31.

Emergency Department Use among Patients with CKD: A Population-Based Analysis.

Ronksley PE, Tonelli M, Manns BJ, Weaver RG, Thomas CM, MacRae JM, Ravani P, Quinn RR, James MT, Lewanczuk R, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):304-314. doi: 10.2215/CJN.06280616. Epub 2017 Jan 24.

32.

Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.

Jun M, James MT, Ma Z, Zhang J, Tonelli M, McAlister FA, Manns BJ, Ravani P, Quinn RR, Wiebe N, Perkovic V, Wilton SB, Winkelmayer WC, Hemmelgarn BR; Alberta Kidney Disease Network.

Am J Kidney Dis. 2017 Jun;69(6):734-743. doi: 10.1053/j.ajkd.2016.10.018. Epub 2016 Dec 18.

PMID:
27998624
33.

Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.

Ronksley PE, Hemmelgarn BR, Manns BJ, Wick J, James MT, Ravani P, Quinn RR, Scott-Douglas N, Lewanczuk R, Tonelli M.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2022-2031. Epub 2016 Oct 6.

34.

Primary care physicians' perceived barriers, facilitators and strategies to enhance conservative care for older adults with chronic kidney disease: a qualitative descriptive study.

Tam-Tham H, Hemmelgarn BR, Campbell DJ, Thomas CM, Fruetel K, Quinn RR, King-Shier KM.

Nephrol Dial Transplant. 2016 Nov;31(11):1864-1870. Epub 2015 Dec 17.

PMID:
26681733
35.

Prevalence of Barriers and Facilitators to Enhancing Conservative Kidney Management for Older Adults in the Primary Care Setting.

Tam-Tham H, King-Shier KM, Thomas CM, Quinn RR, Fruetel K, Davison SN, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2012-2021. Epub 2016 Aug 22.

36.

Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis.

Oliver MJ, Al-Jaishi AA, Dixon SN, Perl J, Jain AK, Lavoie SD, Nash DM, Paterson JM, Lok CE, Quinn RR.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1606-14. doi: 10.2215/CJN.10130915. Epub 2016 Jul 27.

37.

Willingness to participate in a randomized trial comparing catheters to fistulas for vascular access in incident hemodialysis patients: an international survey of nephrologists.

Poinen K, Oliver MJ, Ravani P, Van der Veer SN, Jager KJ, Van Biesen W, Polkinghorne KR, Rosenfeld A, Lewin AM, Dulai M, Quinn RR.

Can J Kidney Health Dis. 2016 Jul 13;3:33. doi: 10.1186/s40697-016-0125-6. eCollection 2016.

38.

Citrate vs. acetate dialysate on intradialytic heparin dose: A double blind randomized crossover study.

Leung KC, Tai DJ, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM.

Hemodial Int. 2016 Oct;20(4):537-547. doi: 10.1111/hdi.12433. Epub 2016 Jun 20.

PMID:
27325599
39.

Patient Education and Peritoneal Dialysis Modality Selection: A Systematic Review and Meta-analysis.

Devoe DJ, Wong B, James MT, Ravani P, Oliver MJ, Barnieh L, Roberts DJ, Pauly R, Manns BJ, Kappel J, Quinn RR.

Am J Kidney Dis. 2016 Sep;68(3):422-33. doi: 10.1053/j.ajkd.2016.02.053. Epub 2016 Apr 26. Review.

PMID:
27125246
40.

Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, James MT, MacRae JM, Palmer SC, Strippoli GF.

Am J Kidney Dis. 2016 Mar;67(3):446-60. doi: 10.1053/j.ajkd.2015.11.013. Epub 2016 Jan 6. Erratum in: Am J Kidney Dis. 2017 Nov;70(5):735.

PMID:
26776537
41.

Pre-emptive correction for haemodialysis arteriovenous access stenosis.

Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, James MT, MacRae JM, Palmer SC, Strippoli GF.

Cochrane Database Syst Rev. 2016 Jan 7;(1):CD010709. doi: 10.1002/14651858.CD010709.pub2. Review.

42.

Selecting Peritoneal Dialysis in the Older Dialysis Population.

Oliver MJ, Quinn RR.

Perit Dial Int. 2015 Nov;35(6):618-21. doi: 10.3747/pdi.2014.00346. Review.

43.

Catheter Insertion and Perioperative Practices Within the ISPD North American Research Consortium.

Wallace EL, Fissell RB, Golper TA, Blake PG, Lewin AM, Oliver MJ, Quinn RR.

Perit Dial Int. 2016 Jul-Aug;36(4):382-6. doi: 10.3747/pdi.2015.00089. Epub 2015 Oct 22.

44.

The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial.

Tai DJ, Leung K, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM; Alberta Kidney Disease Network.

BMC Nephrol. 2015 Aug 25;16:147. doi: 10.1186/s12882-015-0144-z.

45.

Patients with chronic kidney disease and their intent to use electronic personal health records.

Harrison TG, Wick J, Ahmed SB, Jun M, Manns BJ, Quinn RR, Tonelli M, Hemmelgarn BR.

Can J Kidney Health Dis. 2015 Jun 9;2:23. doi: 10.1186/s40697-015-0058-5. eCollection 2015.

46.

Analyzing hospitalization data: potential limitations of Poisson regression.

Weaver CG, Ravani P, Oliver MJ, Austin PC, Quinn RR.

Nephrol Dial Transplant. 2015 Aug;30(8):1244-9. doi: 10.1093/ndt/gfv071. Epub 2015 Mar 25.

PMID:
25813274
47.

Dialysis modality and survival: does the controversy live on?

Merchant AA, Quinn RR, Perl J.

Curr Opin Nephrol Hypertens. 2015 May;24(3):276-83. doi: 10.1097/MNH.0000000000000114. Review.

PMID:
25774747
48.

The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study.

Jun M, James MT, Manns BJ, Quinn RR, Ravani P, Tonelli M, Perkovic V, Winkelmayer WC, Ma Z, Hemmelgarn BR; Alberta Kidney Disease Network.

BMJ. 2015 Feb 3;350:h246. doi: 10.1136/bmj.h246.

49.

Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.

Ravani P, Rossi R, Bonanni A, Quinn RR, Sica F, Bodria M, Pasini A, Montini G, Edefonti A, Belingheri M, De Giovanni D, Barbano G, Degl'Innocenti L, Scolari F, Murer L, Reiser J, Fornoni A, Ghiggeri GM.

J Am Soc Nephrol. 2015 Sep;26(9):2259-66. doi: 10.1681/ASN.2014080799. Epub 2015 Jan 15.

50.

Supplemental Content

Loading ...
Support Center